6 studies on Amyloid beta mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research provides crucial mechanistic insights into how arsenic, a common environmental contaminant, could contribute to Alzheimer's disease pathology. The findings highlight APP upregulation, NEP downregulation,…
These promising preclinical results for NeuroPep-X represent a significant step forward in the development of disease-modifying therapies for Alzheimer's Disease. The observed reductions in amyloid plaques and neuroin…
This comprehensive review underscores the transformative potential of disease-modifying therapies in Alzheimer's disease, moving beyond mere symptomatic relief. The demonstrated ability of new drugs to significantly s…
This research highlights a novel mechanistic link between Aβ pathology, IGF1R nuclear signaling, and aberrant cell cycle re-entry in Alzheimer's disease. Understanding this pathway could open new avenues for therapeut…
This novel organoid model provides a crucial, biologically authentic source of Aβ oligomers, which are notoriously difficult to study in their early, toxic forms. By offering a reliable supply of disease-relevant Aβ s…
This comprehensive review provides a critical roadmap for future Alzheimer's disease research, consolidating vast amounts of data into actionable insights and identifying key areas for therapeutic focus. It underscore…